Retraction
An Interleukin-2-IgG-Fas Ligand Fusion Protein Suppresses Delayed-type Hypersensitivity in Mice by Triggering Apoptosis in Activated T Cells as a Novel Strategy for Immunosuppression
Paper Information
Record ID:
569
Author(s):
Publication Date:
April 15, 2000
Retraction Date:
December 27, 2011
(13.9 years years ago)
Subjects:
Country:
🇩🇪 GermanyArticle Type:
Publisher:
Wolters Kluwer - Lippincott Williams & Wilkins
Open Access:
No
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (7)
7
Total Citations0
Post-Retraction4
Pre-Retraction1
Same DayPaper citing An Interleukin-2-IgG-Fas Ligand Fusion Protein Sup...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing An Interleukin-2-IgG-Fas Ligand Fusion Protein Sup...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing An Interleukin-2-IgG-Fas Ligand Fusion Protein Sup...
Unknown Authors
Unknown Journal
Published: Dec 2011
Same day as retraction
Paper citing An Interleukin-2-IgG-Fas Ligand Fusion Protein Sup...
Unknown Authors
Unknown Journal
Published: Feb 2009
1059 days before retraction
Paper citing An Interleukin-2-IgG-Fas Ligand Fusion Protein Sup...
Unknown Authors
Unknown Journal
Published: Nov 2007
1499 days before retraction
Paper citing Suppression of NF-kappa B survival signaling by ni...
Unknown Authors
Unknown Journal
Published: Feb 2005
2520 days before retraction
Paper citing An Interleukin-2-IgG-Fas Ligand Fusion Protein Sup...
Unknown Authors
Unknown Journal
Published: Mar 2004
2833 days before retraction
Quick Stats
Total Citations:
7
Years Since Retraction:
13.9 years
Open Access:
No
Last Checked:
Never